FDA Clears Apollo TMS Therapy Devices for Adolescent Depression
Apollo transcranial magnetic stimulation (TMS) therapy devices by neurocare group have received FDA clearance for treating adolescents with major depressive disorder (MDD). Major depression affects an estimated 5 million adolescents in the U.S. each year, yet treatment options remain limited. Currently, only two oral antidepressants are FDA-approved for use in this age group, and both […]